PubMed:16920333 / 155-474
Annnotations
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 0-319 | Sentence | denotes | Eslicarbazepine acetate (BIA 2-093, S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo/b,f/azepine-5-carboxamide) is a novel antiepileptic drug, now in Phase III clinical trials, designed with the aim of improving efficacy and safety in comparison with the structurally related drugs carbamazepine (CBZ) and oxcarbazepine (OXC). |
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
3358 | 0-23 | ChemicalEntity | denotes | Eslicarbazepine acetate | MESH:C416835 |
3359 | 25-34 | ChemicalEntity | denotes | BIA 2-093 | MESH:C416835 |
3360 | 36-103 | ChemicalEntity | denotes | S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo/b,f/azepine-5-carboxamide | MESH:C416835 |
3361 | 116-134 | ChemicalEntity | denotes | antiepileptic drug | MESH:D000927 |
3362 | 275-288 | ChemicalEntity | denotes | carbamazepine | MESH:D002220 |
3363 | 290-293 | ChemicalEntity | denotes | CBZ | MESH:D002220 |
3364 | 299-312 | ChemicalEntity | denotes | oxcarbazepine | MESH:C036006 |
3365 | 314-317 | ChemicalEntity | denotes | OXC | MESH:C036006 |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 16-23 | GeneOrGeneProduct | denotes | acetate |
T6 | 25-30 | GeneOrGeneProduct | denotes | BIA 2 |
T7 | 110-115 | GeneOrGeneProduct | denotes | novel |
T8 | 149-152 | GeneOrGeneProduct | denotes | III |
LitCoin-GeneOrGeneProduct-v2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 25-30 | GeneOrGeneProduct | denotes | BIA 2 |
T4 | 110-115 | GeneOrGeneProduct | denotes | novel |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T6 | 0-23 | ChemicalEntity | denotes | Eslicarbazepine acetate | C416835|http://purl.obolibrary.org/obo/CHEBI_87016 |
T8 | 25-34 | ChemicalEntity | denotes | BIA 2-093 | C416835 |
T9 | 45-52 | ChemicalEntity | denotes | acetoxy | http://purl.obolibrary.org/obo/CHEBI_48076 |
T10 | 67-89 | ChemicalEntity | denotes | 5H-dibenzo/b,f/azepine | http://purl.obolibrary.org/obo/CHEBI_47802 |
T11 | 92-103 | ChemicalEntity | denotes | carboxamide | http://purl.obolibrary.org/obo/CHEBI_37622|http://purl.obolibrary.org/obo/CHEBI_23004 |
T13 | 116-134 | ChemicalEntity | denotes | antiepileptic drug | ChemicalEntity |
T14 | 275-288 | ChemicalEntity | denotes | carbamazepine | D002220|http://purl.obolibrary.org/obo/CHEBI_3387 |
T16 | 290-293 | ChemicalEntity | denotes | CBZ | D002220 |
T17 | 299-312 | ChemicalEntity | denotes | oxcarbazepine | D000078330|http://purl.obolibrary.org/obo/CHEBI_7824 |
T19 | 314-317 | ChemicalEntity | denotes | OXC | D000078330 |
LitCoin-NCBITaxon-2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 25-28 | OrganismTaxon | denotes | BIA |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T19 | 314-317 | ChemicalEntity | denotes | OXC | D000078330 |
T17 | 299-312 | ChemicalEntity | denotes | oxcarbazepine | http://purl.obolibrary.org/obo/CHEBI_7824|D000078330 |
T16 | 290-293 | ChemicalEntity | denotes | CBZ | D002220 |
T14 | 275-288 | ChemicalEntity | denotes | carbamazepine | D002220|http://purl.obolibrary.org/obo/CHEBI_3387 |
T13 | 116-134 | ChemicalEntity | denotes | antiepileptic drug | ChemicalEntity |
T11 | 92-103 | ChemicalEntity | denotes | carboxamide | http://purl.obolibrary.org/obo/CHEBI_23004|http://purl.obolibrary.org/obo/CHEBI_37622 |
T10 | 67-89 | ChemicalEntity | denotes | 5H-dibenzo/b,f/azepine | http://purl.obolibrary.org/obo/CHEBI_47802 |
T9 | 45-52 | ChemicalEntity | denotes | acetoxy | http://purl.obolibrary.org/obo/CHEBI_48076 |
T8 | 25-34 | ChemicalEntity | denotes | BIA 2-093 | C416835 |
T6 | 0-23 | ChemicalEntity | denotes | Eslicarbazepine acetate | http://purl.obolibrary.org/obo/CHEBI_87016|C416835 |
T36705 | 25-28 | OrganismTaxon | denotes | BIA |